Anti-CD123 Targeted Therapy with Talacotuzumab in Advanced MDS and AML after Failing Hypomethylating Agents - Final Results of the Samba Trial

Anne Sophie Kubasch, Uwe Platzbecker, Katharina S. Götze et al.|Blood|2018

Cited by 17